Principal Investigator

Pierre Thibault

Proteomics and Mass Spectrometry

Subscribe to the newsletter

Possessing a Ph.D. in Analytical Chemistry from the Université de Montréal (1988), Pierre Thibault began his career with the National Research Council of Canada as a protein chemistry Investigator. Between 2001 and 2004, he operated the Protein Analysis Department at Caprion Pharmaceuticals.

He then joined IRIC where he operates the Proteomics Research Unit and the Center for Advanced Proteomics and Chemogenomics Analyses (CAPCA). Pierre Thibault is also a Professor in the Department of Chemistry and an Accredited Member of the Department of Biochemistry of the Faculty of Medicine.

Principal Investigator, Proteomics and Bioanalytical Mass Spectrometry Research Unit, IRIC
Proteomics Core Facility Scientific direction

Professor, Department of Chemistry, Faculty of Arts and Sciences, Université de Montréal

Accredited Member, Department of Biochemistry, Faculty of Medicine, Université de Montréal

Adjunct Professor, Department of Anatomy and Cell Biology, McGill University

Research unit on proteomics and bioanalytical mass spectrometry

Marcelle-Coutu Pavilion, 2306-17

Phone (office)
(514) 343-6111, ext. 6910
Fax
(514) 343-7780
Email
pierre.thibault@umontreal.ca
Apply for a M.Sc. or a Ph.D.

Proteomics and Mass Spectrometry

Pierre Thibault’s laboratory uses quantitative proteomics and bioanalytical mass spectrometry expertise to study the molecular mechanisms and the post-translational modifications that regulate the function of proteins involved in immunity and signalling in cells.

Discover the research unit View the research team

Research topics

Publications

  • July 8, 2024

    Targeting of human cancer stem cells predicts efficacy and toxicity of FDA-approved oncology drugs.

    Vojnits K, Feng Z, Johnson P, Pfammatter S, Thibault P, Bhatia M
    Cancer Lett 2024-07-08 ;217108

  • July 2, 2024

    Comprehensive proteomic analysis of HCoV-OC43 virions and virus-modulated extracellular vesicles.

    Joharinia N, Bonneil E, Grandvaux N, Thibault P, Lippé R
    J Virol 2024-07-02 ;e0085024

  • June 4, 2024

    Immunotherapeutic targeting of surfaceome heterogeneity in AML.

    Bordeleau ME, Audemard E, Métois A, Theret L, Lisi V, Farah A, Spinella JF, Chagraoui J, Moujaber O, Aubert L, Khakipoor B, Mallinger L, Boivin I, Mayotte N, Hajmirza A, Bonneil E, Béliveau F, Pfammatter S, Feghaly A, Boucher G, Gendron P, Thibault P, Barabé F, Lemieux S, Richard-Carpentier G, Hébert J, Lavallée VP, Roux PP, Sauvageau G
    Cell Rep 2024-06-04 ;43( 6 ):114260

  • June 1, 2024

    K29-linked free polyubiquitin chains affect ribosome biogenesis and direct ribosomal proteins to the intranuclear quality control compartment.

    Garadi Suresh H, Bonneil E, Albert B, Dominique C, Costanzo M, Pons C, Masinas MPD, Shuteriqi E, Shore D, Henras AK, Thibault P, Boone C, Andrews BJ
    Mol Cell 2024-06-01 ;

  • See all publications

Awards and distinctions

  • Acfas Urgel-Archambault Award, Association francophone pour le savoir, 2018

  • Tony Pawson Award, Canadian National Proteomics Network, 2017

  • SCC Maxxam Award, Maxxam, 2012